BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of meeting with Analyst/Institutional Investor.25-08-2023
25-08-2023
BIOCON LTD. - 532523 - Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations, 2015.
Meeting conducted with Institutional Investors/Research Analysts24-08-2023
BIOCON LTD. - 532523 - Announcement Under Regulation 30
Details pursuant to Regulation 30(4) of SEBI LODR.21-08-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call Q1 FY2421-08-2023
BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Voting Results of 45th AGM.16-08-2023
BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report for 45th AGM16-08-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of meeting with Analysts/Institutional Investors14-08-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication- Unaudited financial results for the quarter ended June 30, 2023.12-08-2023
Biocon Results Earnings Call for Q1FY24
Conference Call with Biocon Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Kiran Mazumdar Shaw and Senior Team12-08-2023
Biocon may list biosimilars business by 2025 first half - CEO
Biocon Biologics, a fully integrated subsidiary of Biocon Ltd, focuses on making biosimilars, with key revenue-generating markets being the United States and Europe.11-08-2023